A drug that can kill cancer cells while leaving normal cells unharmed may be within our grasp thanks to research from A*STAR, although the approach is still several years away from clinical trials.
Jul 27, 2016
0
12
Metformin, a medication routinely used by millions of people with type 2 diabetes, may also play an unexpected role in blocking a significant cause of preterm birth, according to research findings published July 25.
Jul 25, 2016
0
4
Scientists at the Stowers Institute for Medical Research have reported a detailed description of how function-impairing mutations in polr1c and polr1d genes cause Treacher Collins syndrome (TCS), a rare congenital craniofacial ...
Jul 22, 2016
0
61
Cancerous tumors must be fed. Their unregulated growth requires a steady stream of blood flow and nutrients. Thus, one way that researchers have tried to wipe out cancer is to target cells undergoing the metabolic shifts ...
Jul 6, 2016
0
242
The successful results of a University of Liverpool led drug trial aimed at developing new therapeutic approaches to cancer have been presented at two American medical conferences.
Jun 6, 2016
0
15
Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common ...
May 24, 2016
0
1
A metabolic pathway that is up-regulated in certain breast cancers promotes the disease's progression by activating a cell signaling protein called Arf6, according to a paper published in the Journal of Cell Biology. The ...
Apr 6, 2016
0
24
A large study by researchers with the UC Davis MIND Institute has found that a gene whose role is to suppress cellular damage from environmental stressors is nearly twice as likely to be defective in children with autism ...
Mar 31, 2016
0
2
Researchers from the universities of Granada, Barcelona and Jaen prove that maslinic acid, a natural triterpene found in high concentrations in the waxy skin of olives is effective in Caco-2 p53-deficient colon adenocarcinoma ...
Mar 10, 2016
0
4
P53, a tumor suppressor gene that is mutated and inactivated in the vast majority of cancers, has often been described as the "guardian of the genome" because of its protective effects against cancer. Now, researchers at ...
Mar 3, 2016
0
4
